In vitro antimicrobial activity of defensins against ocular pathogens

Archives of Ophthalmology
J S CullorT Reid

Abstract

New approaches to antimicrobial therapy for ocular pathogens must overcome organisms that are resistant to current therapeutic modalities. This investigation examined the antimicrobial activity of novel antimicrobial neutrophil peptides (defensins NP-1 and NP-5) against isolates from clinical ocular microbial infections in humans and horses. The test panel of human clinical isolates included Candida albicans, an alpha-hemolytic Streptococcus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Morganella morganii. The test panel of equine pathogens included three clinical isolates of P aeruginosa and two clinical isolates of Staphylococcus aureus. The equine isolates were chosen for their relative resistance to commonly employed antimicrobial therapy. The two defensins differed markedly in their bactericidal activity. Defensin NP-5, at a 50-micrograms/mL concentration, exhibited minimal bactericidal activity against the majority of isolates of the test panel. The inferior microbicidal activity of NP-5 is consistent with previously published results. However, at this concentration, NP-5 did exhibit appreciable bacteriostatic activity against human ocular pathogens M morganii (74%), alpha-hemolytic Streptococcus (57%), and P ae...Continue Reading

Citations

Jan 1, 1994·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·P A Thomas
Aug 5, 2014·Cellular and Molecular Life Sciences : CMLS·Satya Sree N KolarMaria Luisa Mangoni
Oct 12, 2000·Clinical Microbiology Reviews·S A KlotzS I Butrus
Apr 20, 2006·The British Journal of Ophthalmology·A M McDermottC J Murphy
Jul 16, 2005·Current Eye Research·Y Jerold GordonAlison M McDermott
Nov 1, 2006·The Ocular Surface·James P McCulley, Ward E Shine
Jan 12, 2007·The Ocular Surface·Alison M McDermott
May 16, 2008·International Endodontic Journal·K L BartieM A O Lewis
Dec 25, 2008·Journal of Peptide Science : an Official Publication of the European Peptide Society·Shouping LiuRoger Beuerman
Jun 29, 2004·Progress in Retinal and Eye Research·Michael E Johnson, Paul J Murphy
Nov 6, 2012·International Journal of Antimicrobial Agents·Nádia C SilvaManuela Pintado
Aug 25, 2012·Current Eye Research·Aihua TangRichard J O'Callaghan
Sep 23, 2006·Atherosclerosis·Hisham NassarAbd Al-Roof Higazi
Nov 24, 1998·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·A WeinbergB A Dale
Dec 1, 1994·Cadernos de saúde pública·M da G NascimentoM E Selsted
May 7, 2008·Biochemistry. Biokhimii︠a︡·R Sariri, H Ghafoori
May 20, 1999·Biopolymers·D Andreu, L Rivas
Jul 30, 2016·Veterinary Ophthalmology·Todd L MarloRajiv R Mohan
Mar 20, 2008·Chembiochem : a European Journal of Chemical Biology·Shouping LiuRoger W Beuerman
Nov 13, 2004·Clinical and Diagnostic Laboratory Immunology·Tetsuro OkamotoTokio Osaki
Sep 15, 2020·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Shyam Sunder Tummanapalli, Mark Dp Willcox
May 1, 1995·Pharmacology & Therapeutics·T Ganz, R I Lehrer
Nov 16, 2018·The Journal of Physical Chemistry. B·Rabeta YeasminLiqun Zhang
Apr 21, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohammad Hassan BaigInho Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.